chr2:25457242:C>G Detail (hg19) (DNMT3A)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr2:25,457,242-25,457,242 |
hg38 | chr2:25,234,373-25,234,373 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_001320893.1:c.1976G>C | NP_001307822.1:p.Arg659Pro |
NM_022552.4:c.2645G>C | NP_072046.2:p.Arg882Pro | |
NM_153759.3:c.2078G>C | NP_715640.2:p.Arg693Pro |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 1 |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:[No Data.] |
ToMMo:[No Data.] | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:<0.001 |
Prediction
ClinVar
Clinical Significance |
![]() ![]() |
Review star | ![]() |
Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
Myelodysplastic syndromes |
![]() |
MGS000005
(TMGS000006) |
Keizo Horibe | National Hospital Organization Nagoya Medical Center |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2016-05-31 | no assertion criteria provided | lung adenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | myelodysplastic syndrome |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | acute myeloid leukemia |
![]() |
Detail |
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.560 | Leukemia, Myelocytic, Acute | To determine whether mutant IDH enzymes are valid targets for cancer therapy, we... | BeFree | 25795706 | Detail |
0.018 | Leukemia, Myelocytic, Acute | To determine whether mutant IDH enzymes are valid targets for cancer therapy, we... | BeFree | 25795706 | Detail |
0.018 | Leukemia, Myelocytic, Acute | The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT... | BeFree | 24656771 | Detail |
0.001 | Leukemogenesis | Moreover, DNMT3A-R882H increased the CDK1 protein level and enhanced cell-cycle ... | BeFree | 24497509 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NM_022552.5(DNMT3A):c.2645G>C (p.Arg882Pro) AND Lung adenocarcinoma | ClinVar | Detail |
NM_022552.5(DNMT3A):c.2645G>C (p.Arg882Pro) AND Myelodysplastic syndrome | ClinVar | Detail |
NM_022552.5(DNMT3A):c.2645G>C (p.Arg882Pro) AND Acute myeloid leukemia | ClinVar | Detail |
To determine whether mutant IDH enzymes are valid targets for cancer therapy, we created a mouse mod... | DisGeNET | Detail |
To determine whether mutant IDH enzymes are valid targets for cancer therapy, we created a mouse mod... | DisGeNET | Detail |
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its a... | DisGeNET | Detail |
Moreover, DNMT3A-R882H increased the CDK1 protein level and enhanced cell-cycle activity, thereby co... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs147001633 dbSNP
- Genome
- hg19
- Position
- chr2:25,457,242-25,457,242
- Variant Type
- snv
- Reference Allele
- C
- Alternative Allele
- G
- East Asian Chromosome Counts (ExAC)
- 8648
- East Asian Allele Counts (ExAC)
- 1
- East Asian Heterozygous Counts (ExAC)
- 1
- East Asian Homozygous Counts (ExAC)
- 0
- East Asian Allele Frequency (ExAC)
- 1.1563367252543941E-4
- Chromosome Counts in All Race (ExAC)
- 121122
- Allele Counts in All Race (ExAC)
- 7
- Heterozygous Counts in All Race (ExAC)
- 7
- Homozygous Counts in All Race (ExAC)
- 0
- Allele Frequency in All Race (ExAC)
- 5.7792969072505406E-5
Genome browser